Eli Lilly secures long-awaited FDA approval for its obesity pill. Here’s what to know

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street.

Comments are closed.